Tetrahydrolipstatin containing compositions. Stabilizing agent shows greater rate of .

Tetrahydrolipstatin containing compositions. To read more about how this page was constructed, please visit the PubChem patents help page. Jan 6, 1998 · Product containing tetrahydrolipstatin as the active ingredient and pharmaceutically acceptable excipients, characterized in that it is in the form of particles with a diameter of 0. Pat. 25 to 2 mm; and pharmaceutical preparations or compositions for oral administration containing the product. Mar 28, 2001 · The use of THL as medicament, particularly as anti-obesity agent, and pharmaceutical compositions containing THL as active agent are described in US Patent No. It is also an FDA approved drug under name as orlistat that is currently marketed as Xenical® for the treatment of obesity now. The use of THL as medicament, particularly as anti-obesity agent, and pharmaceutical compositions containing THL as active agent are described in U. PRODUCT CONTAINING TETRAHYDROLIPSTATIN AS THE ACTIVE INGREDIENT AND PHARMACEUTICALLY ACCEPTABLE EXCIPIENTS, CHARACTERIZED IN THAT IT IS IN THE FORM OF PARTICLES WITH A DIAMETER OF 0. . Jan 24, 1998 · Product containing tetrahydrolipstatin as the active ingredient and pharmaceutically acceptable excipients, characterized in that it is in the form of particles with a diameter of 0. FIELD: medicine. No. S. Tetrahydrolipstatin (THL, 2) is a semi-synthetic derivative of lipstatin. Jan 24, 1998 · Abstract Product containing tetrahydrolipstatin as the active ingredient and pharmaceutically acceptable excipients, characterized in that it is in the form of particles with a diameter of 0. Tetrahydrolipstatin ("THL") is an inhibitor of pancreatic lipase and is known by the generic name orlistat. Stabilizing agent shows greater rate of Product containing tetrahydrolipstatin as the active ingredient and pharmaceutically acceptable excipients, characterized in that it is in the form of particles with a diameter of 0. 25 TO 2 MM; AND PHARMACEUTICAL PREPARATIONS OR COMPOSITIONS FOR ORAL ADMINISTRATION CONTAINING THE PRODUCT. SUBSTANCE: invention relates to compositions consisting of great number of particles with mean diameter about from 0. 25 to 2 mm; and pharmaceutical preparation s or compositions for oral administration containing the product. Product containing tetrahydrolipstatin as the active ingredient and pharmaceutically acceptable excipients, characterized in that it is in the form of particles with a diameter of 0. The use of THL as medicament, particularly as anti-obesity agent, and pharmaceutical compositions containing THL as active agent are described in U. 25 mm to 2 mm that can be used for treatment of patients with obesity. Particles have tetrahydrolipstatin, stabilizing agent of its hydrolytic decomposition and at least one pharmaceutically acceptable excipient, not less. 4,598,089. This includes chemicals mentioned, as reported by PubChem contributors, as well as other content, such as title, abstract, and International Patent Classification (IPC) codes. eg a9za xp 3u3az suxf tow2 0vvu tkby 0adll gtzy00